Nicole R. Hadas, SVP, General Counsel, Secretary at Akebia Therapeutics, Inc. (AKBA), sold 1,554 shares at $14.26 ($22K) on 2017-07-03, disclosed to the SEC on 2017-07-06.
Open-market sale of $22k AKBA by SVP, General Counsel, Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |